Hiroshige Mikamo
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 41
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 42
- Antifungal resistance and susceptibility 33
- Clostridium difficile and Clostridium perfringens research 21
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 33
- Microbiology top 2%
-
- Antibiotics Pharmacokinetics and Efficacy 44
-
- Pneumonia and Respiratory Infections 37
-
- Bacterial biofilms and quorum sensing 18
Hiroshige Mikamo
223 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 129
- Applied Microbiology and Biotechnology 227
- Molecular Medicine 466
- Infectious Diseases 1.3k
- Clinical Biochemistry 447
- Microbiology 247
Countries citing papers authored by Hiroshige Mikamo
This map shows the geographic impact of Hiroshige Mikamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshige Mikamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshige Mikamo more than expected).
Fields of papers citing papers by Hiroshige Mikamo
This network shows the impact of papers produced by Hiroshige Mikamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshige Mikamo. The network helps show where Hiroshige Mikamo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroshige Mikamo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 17 | |
| 7 | 2019 | 2 | |
| 8 | 2019 | 6 | |
| 9 | 2019 | 3 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 4 | |
| 12 | 2018 | 9 | |
| 13 | 2017 | 4 | |
| 14 | Evaluation of the modified sodium mercaptoacetic acid double disk synergy test for detecting the metallo-β-lactamase producing Enterobacteriaceae | 2017 | 1 |
| 15 | 2016 | 21 | |
| 16 | 2012 | 0 | |
| 17 | 2010 | 6 | |
| 18 | Therapeutic drug monitoring survey of anti-MRSA agents in Japan | 2010 | 4 |
| 19 | Survey on once-daily therapy with ceftriaxone for pediatric bacterial infections | 2007 | 1 |
| 20 | Bacterial flora detected in the uterine endometrial cavity of normal puerperae on the puerperal first day and on the puerperal fifth day after incidental use of lenampicillin (LAPC) | 1992 | 1 |
About Hiroshige Mikamo
Hiroshige Mikamo is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 235 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (44 papers), Antimicrobial Resistance in Staphylococcus (42 papers), Antibiotic Resistance in Bacteria (41 papers), Pneumonia and Respiratory Infections (37 papers), Antifungal resistance and susceptibility (33 papers), Bacterial Identification and Susceptibility Testing (33 papers), Clostridium difficile and Clostridium perfringens research (21 papers) and Bacterial biofilms and quorum sensing (18 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (227 citations), Molecular Medicine (466 citations) and Infectious Diseases (1.3k citations). Hiroshige Mikamo has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Yuka Yamagishi, Mao Hagihara, Yusuke Koizumi, Hideo Kato, Nobuhiro Asai, Hiroyuki Suematsu, Yoshio Takesue, Daisuke Sakanashi, Naoya Nishiyama and Yukihiro Hamada. Their work appears in journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.